November 9-11, 2020 | Virtual Conference

SPEAKERS

Sarah Yim, M.D.

Director
Office of Therapeutic Biologics and Biosimilars, CDER’s Office of New Drugs (OND), FDA

Siva Vaithiyalingam, PhD

Vice President of Regulatory Affairs
Cipla LTD

Scott D. Tomsky

VP, North America
Regulatory Affairs, Generics, Teva

Gerald Dal Pan, M.D., MHS

Director
Office of Surveillance and Epidemiology, CDER, FDA

Doug Long

Vice President of Industry Relations
IQVIA

Kiran Krishnan, PhD

Senior Vice President, Global Regulatory Affairs
Apotex Inc.

Kurt R. Karst, JD

Director
Hyman, Phelps & McNamara, P.C.

Lynne Ensor, PhD

Vice President, Technical
Parexel International

Martin Ehlert, PhD

Vice President
Research and Development, Apotex Inc.

Charlie DiLiberti

President
Montclair Bioequivalence Services, LLC

Sally Choe, PhD

Director
Office of Generic Drugs (OGD), CDER, FDA

Donald D. Ashley, JD

Director
Office of Compliance, CDER, FDA

Get Started + Register

Whether you are an AAM member, general attendee, speaker or exhibitor, you can be part of the premier scientific and regulatory conference for the U.S. generics and biosimilars industry.

Get Started + Register

Whether you are an AAM member, general attendee, speaker or exhibitor, you can be part of the premier scientific and regulatory conference for the U.S. generics and biosimilars industry.

Get Started + Register

Whether you are an AAM member, general attendee, speaker or exhibitor, you can be part of the premier scientific and regulatory conference for the U.S. generics and biosimilars industry.

Skip to content